GSK plans 60 job cuts at Quebec vaccine plant

GlaxoSmithKline ($GSK) plans to cut 9% of its Quebec City workforce, with most of the cuts coming at a vaccines plant that produces seasonal flu shots. About 60 jobs are expected to be affected by the move. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.